Frederick R Appelbaum

Publication Activity (10 Years)

Years Active: 2014-2021
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Top Venues

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner, Ben L Sanford, Kristina Laumann, Susan Geyer, Clara D Bloomfield, Christian Thiede, Thomas W Prior, Konstanze Döhner, Guido Marcucci, Maria Teresa Teresa Voso, Rebecca B Klisovic, Ilene Galinsky, Andrew H Wei, Jorge Sierra, Miguel Angel Sanz, Joseph M Brandwein, Theo de Witte, Dietger Niederwieser, Frederick R Appelbaum, Bruno C Medeiros, Martin S Tallman, Jürgen Krauter, Richard F Schlenk, Arnold Ganser, Hubert Serve, Gerhard Ehninger, Sergio Amadori, Insa Gathmann, Hartmut Döhner, Richard M Stone
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial. Leukemia 35 (9) (2021)
Roland Bruno Walter, Frederick R Appelbaum
Next-generation sequencing for measuring minimal residual disease in AML. Nature reviews. Clinical oncology 15 (8) (2019)
Frederick R Appelbaum, Irwin D Bernstein
Gemtuzumab ozogamicin for acute myeloid leukemia. Blood 130 (22) (2017)
Mohamed Lotfy Sorror, Paul J Martin, Rainer F Storb, Shailender Bhatia, Richard T Maziarz, Michael A Pulsipher, Michael B Maris, Christopher Davis, H Joachim Deeg, Stephanie J Lee, David G Maloney, Brenda M Sandmaier, Frederick R Appelbaum, Theodore A Gooley
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood 124 (2) (2014)